Skip to main content
Full access
Commentary
Published Online: 6 September 2024

Ethical (Re) Considerations of Involuntary Hospitalization

Publication: American Journal of Psychiatry Residents' Journal
In October 2023, with the passage of Bill 43, California adopted several changes that expand involuntary hospitalization and conservatorship law. Notably, patients can now be considered gravely disabled, or unable to meet their basic needs, as a result of substance use disorders, in addition to other mental disorders, such as schizophrenia (1). California joins 35 other states that allow some form of involuntary commitment of patients with substance use disorders (2). Patients with substance use disorders can be held involuntarily up to 47 days in California hospitals (or longer if conservatorship is pursued) (1). This policy change, which will affect hundreds of patients, raises important ethical considerations.
As physicians, we are taught to consider four basic ethical principles: beneficence, nonmaleficence, autonomy, and justice. By definition, involuntary commitment sacrifices patient autonomy and prioritizes beneficence, our duty to act in ways that benefit patients (3). Hospitalization of patients with substance use disorders promotes their well-being by stopping—or at least pausing—further damage to their physical, relational, and emotional health from substance use. Thus, the ethical justification to prioritize beneficence over autonomy—that the emotional injury of being held against one’s will is worth it—largely depends on whether involuntary treatment for substance use disorders works. Studies to date have yielded mixed results (4). Furthermore, few states track utilization of involuntary commitment and treatment for substance use disorders, and there are few data examining the likelihood of remission by type of compelled treatment (5). How, then, can we ensure that the benefit to patients is real and not just assumed?
Nonmaleficence—our duty not to harm patients (3)—raises additional questions. Almost one-third of patients relapse the day of release from mandated substance abuse treatment (6), and data show that periods of forced abstinence increase the risk of fatal drug overdose (7). Is involuntary hospitalization just setting patients up to fail? And could forced detoxification, which often involves both physical discomfort and emotional resentment, without clear benefit be considered harmful to patients?
Justice, the fourth ethical principle regarding our duty to provide fair and equitable treatment (3), introduces a classification question. Are substance use disorders the same as other mental health conditions, such as schizophrenia, for which involuntary treatment is generally supported? We routinely administer treatment involuntarily to patients with psychotic disorders despite no guarantee of maintaining remission. Perhaps patients with psychotic disorders who stop taking their psychotropic medications on leaving the hospital are not dissimilar to patients with substance use disorders who resume substance use after discharge. That said, it is easier to determine when a patient is no longer floridly manic or psychotic than it is to determine whether a patient has sufficiently restored enough cognitive control, which is weakened by long-term substance use (8), to maintain sobriety after a period of forced treatment.
A final ethical question that is much too large and important to address in the confines of this short commentary is how this may affect ethnic and racial minorities who are more likely to be in the legal system (9). Could this be another instance of taking away autonomy from groups whose autonomy has already been denied by society for years?
Despite ethical uncertainty, California can implement this bill in a way that maximizes beneficence and minimizes nonmaleficence. This should include providing clinicians with specific guidelines, including what types of treatment can be mandated, to ensure that involuntary hospitalizations are more than 3-day forced detoxifications. The state should also track involuntary hospitalization rates, treatment methods, and outcomes in a variety of hospitals to properly evaluate the efficacy of the new bill. With more time and appropriate data, I am hopeful that legislation can be crafted that minimizes the tension between autonomy and beneficence.

Acknowledgments

The author thanks Alaina Burns, M.D., for editorial advice.

References

1.
California Legislative Information: SB 43. Eggman, behavioral health (Cal 2023). https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202320240SB43
2.
National Judicial Opioid Task Force: Involuntary commitment and guardianship laws for persons with a substance use disorder. Williamsburg, Va, National Center for State Courts, 2018. https://www.opioidlibrary.org/wp-content/uploads/2019/06/NCSC_Inv-Comm-and-Guard-Laws-for-SUD-Final2.pdf
3.
Varkey B: Principles of clinical ethics and their application to practice. Med Princ Pract 2021;30:17–28
4.
Klag S, O’Callaghan F, Creed P: The use of legal coercion in the treatment of substance abusers: an overview and critical analysis of thirty years of research. Subst Use Misuse 2005;40:1777–1795
5.
Christopher PP, Pinals DA, Stayton T, et al: Nature and utilization of civil commitment for substance abuse in the United States. J Am Acad Psychiatry Law 2015;43:313–320
6.
Christopher PP, Anderson B, Stein MD: Civil commitment experiences among opioid users. Drug Alcohol Depend 2018;193:137–141
7.
Strang J, McCambridge J, Best D, et al: Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003;326:959–960
8.
Murnane KS, Edinoff AN, Cornett EM, et al: Updated perspectives on the neurobiology of substance use disorders using neuroimaging. Subst Abuse Rehabil 2023; 99–111
9.
Niv N, Pham R, Hser YI: Racial and ethnic differences in substance abuse service needs, utilization, and outcomes in California. Psychiatr Serv 2009;60(10):1350–1356

Information & Authors

Information

Published In

Go to American Journal of Psychiatry Residents' Journal
American Journal of Psychiatry Residents' Journal
Pages: 7 - 8

History

Published online: 6 September 2024
Published in print: September 6, 2024

Authors

Details

Erin Hegarty, M.D., M.A.
Dr. Hegarty is a third-year resident in psychiatry at the University of California, Los Angeles.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share